Imaging tumour cell metabolism using hyperpolarized 13C magnetic resonance spectroscopy.

Patients with similar tumour types frequently show different responses to the same therapy. The development of new treatments would benefit, therefore, from imaging methods that allow an early assessment of treatment response in individual patients, allowing rapid selection of the most effective treatment. We have been using (13)C MRSI (magnetic resonance spectroscopic imaging) of tumour cell metabolism, using hyperpolarized (13)C-labelled cellular metabolites, to detect treatment response. Nuclear spin hyperpolarization can increase sensitivity in the magnetic resonance experiment >10,000 times, allowing us to image labelled cell substrates in vivo and their subsequent metabolism. We showed that exchange of hyperpolarized (13)C label between lactate and pyruvate, catalysed by lactate dehydrogenase, was decreased in treated tumours undergoing drug-induced cell death, and that tissue pH could be imaged from the ratio of the signal intensities of hyperpolarized H(13)CO(3)(-) and (13)CO(2) following intravenous injection of hyperpolarized H(13)CO(3). Tumour cell glutaminase activity, a potential measure of cell proliferation, can be determined using hyperpolarized [5-(13)C]glutamine, and treatment-induced tumour cell necrosis can be imaged in vivo from measurements of the conversion of hyperpolarized [1,4-(13)C(2)]fumarate into malate. Since these substrates are endogenous and, in some cases, have already been safely infused into patients, these techniques have the potential to translate to the clinic.

[1]  Seth M Steinberg,et al.  A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. , 2003, The New England journal of medicine.

[2]  Jan Henrik Ardenkjaer-Larsen,et al.  Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis. , 2006, Cancer research.

[3]  J. Mazziotta,et al.  Positron emission tomography: human brain function and biochemistry. , 1985, Science.

[4]  Albert P. Chen,et al.  Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. , 2008, Cancer research.

[5]  Ferdia A Gallagher,et al.  A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment. , 2009, Neoplasia.

[6]  G. Radda,et al.  In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance , 2008, Proceedings of the National Academy of Sciences.

[7]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[8]  Craig R. Malloy,et al.  Hyperpolarized 13C allows a direct measure of flux through a single enzyme-catalyzed step by NMR , 2007, Proceedings of the National Academy of Sciences.

[9]  A. Overhauser Polarization of Nuclei in Metals , 1953 .

[10]  N. Madias,et al.  Management of Life-Threatening AcidBase Disorders , 1998 .

[11]  Warren S. Warren,et al.  Increasing Hyperpolarized Spin Lifetimes Through True Singlet Eigenstates , 2009, Science.

[12]  Wiklund Ra,et al.  First of two parts , 1997 .

[13]  W. Souba,et al.  Modulation of Cellular Proliferation Alters Glutamine Transport and Metabolism in Human Hepatoma Cells , 1994, Annals of surgery.

[14]  Sarah E Bohndiek,et al.  Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors , 2009, Proceedings of the National Academy of Sciences.

[15]  D. Collins,et al.  Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.

[16]  M. Jacobs,et al.  Choline metabolism in cancer: implications for diagnosis and therapy , 2006, Expert review of molecular diagnostics.

[17]  John Kurhanewicz,et al.  Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy. , 2010, Cancer research.

[18]  Pernille R. Jensen,et al.  Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate , 2008, Nature.

[19]  Jan Henrik Ardenkjaer-Larsen,et al.  Dynamic Nuclear Polarization of [1-13C]pyruvic acid at 4.6 tesla. , 2009, Journal of magnetic resonance.

[20]  Henrik Kacser On Parts and Wholes in Metabolism , 1986 .

[21]  F. Gallagher,et al.  Biomedical applications of hyperpolarized 13C magnetic resonance imaging , 2009 .

[22]  Kevin Brindle,et al.  New approaches for imaging tumour responses to treatment , 2008, Nature Reviews Cancer.

[23]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.

[24]  G K Radda,et al.  NMR studies of tissue metabolism. , 1981, Annual review of biochemistry.

[25]  Jan Wolber,et al.  Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy , 2007, Nature Medicine.

[26]  H. Mackay,et al.  Targeting the protein kinase C family: are we there yet? , 2008, Nature Reviews Cancer.

[27]  Rebekah McLaughlin,et al.  Magnetization transfer measurements of exchange between hyperpolarized [1‐13C]pyruvate and [1‐13C]lactate in a murine lymphoma , 2010, Magnetic resonance in medicine.

[28]  W. Souba,et al.  Determinants of glutamine dependence and utilization by normal and tumor‐derived breast cell lines , 1998, Journal of cellular physiology.

[29]  N. Madias,et al.  Management of life-threatening acid-base disorders. Second of two parts. , 1998, The New England journal of medicine.

[30]  J. Ardenkjær-Larsen,et al.  Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Peter Magnusson,et al.  Cardiac metabolism measured noninvasively by hyperpolarized 13C MRI , 2008, Magnetic resonance in medicine.

[32]  F. Gallagher,et al.  13C MR spectroscopy measurements of glutaminase activity in human hepatocellular carcinoma cells using hyperpolarized 13C‐labeled glutamine , 2008, Magnetic resonance in medicine.

[33]  Julian L. Griffin,et al.  Metabolic profiles of cancer cells , 2004, Nature Reviews Cancer.

[34]  Otto Muzik,et al.  Imaging proliferation in vivo with [F-18]FLT and positron emission tomography , 1998, Nature Medicine.

[35]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[36]  R.J. Gillies,et al.  pH imaging , 2004, IEEE Engineering in Medicine and Biology Magazine.